Charts Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
NYSE
16:00:02 2026-08-20 EDT
|
5-day change | 1st Jan Change | ||
| 291.45 USD | +0.50% |
|
+3.62% | +46.10% |
| 08-20 | Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing | MT |
| 08-20 | Charles River, Medigen Partner on Multivalent Enterovirus Vaccine | MT |
Chart: Technical Analysis
Stock exchange
NYSE
CRL 291.45 $
+0.50%
309M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
NYSE
| CRL | 291.45USD | +0.50% | 309M $ | |
CBOE
| CRL | 291.48USD | +0.58% | 12.97M $ | |
Tradegate
| RV6 | 249.70EUR | +0.48% | 18.73K € | |
Mexican S.E.
| CRL * | 4,720.00MXN | -1.97% | 61.36K $ | |
Deutsche Boerse AG
| RV6 | 248.50EUR | +0.28% | 0 € | |
Börse Stuttgart
| RV6 | 248.70EUR | +3.02% | 0 € | |
Boerse Muenchen
| RV6 | 250.20EUR | 0.00% | 0 € | |
Berne S.E.
| RV6 | 238.76CHF | +2.43% | 0 CHF |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 319 | 376.78 | 321.73 |
| Spread/Res. | -8.64% | -22.65% | -9.41% |
| Spread/Supp. | +16.27% | +33.26% | +41.62% |
| Support | 250.66 | 218.7 | 205.79 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- CRL Stock
- Charts Charles River Laboratories International, Inc.
Select your edition
All financial news and data tailored to specific country editions

















